1 | Albendazole | Albendazole 2件: Albendazole; Albendazole (eskazole); | 1件: D00134 D00134 💬 |
- |
- |
005 11件: 5 , 6 , 7 , 28, 51, 67, 86, 96, 97, 114, 127 💬 |
2 | Botulinum toxin type A | Botulinum toxin type a 6件: Botulinum toxin type a; Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle; Botulinum toxin type a 200u; Botulinum toxin type a 300u; Botulinum toxin type a infiltrations; Clostridium botulinum toxin type a; | 1件: D00783 D00783 💬 |
1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
002 13件: 2 , 5 , 6 , 7 , 13, 15, 17, 36, 51, 70, 113, 149, 226 💬 |
3 | Creatine | Creatine 4件: Creatine; Creatine monohydrate; Creatine-13c; Pyruvate, creatine, niacinamide; | - |
- |
- |
001 12件: 1 , 2 , 5 , 6 , 8 , 13, 46, 49, 50, 113, 156, 201 💬 |
4 | Davunetide | Davunetide 2件: Davunetide; Davunetide (al-108, nap); | 1件: D09401 D09401 💬 |
- |
- |
005 3件: 5 , 7 , 127 💬 |
5 | Donepezil | Donepezil 7件: Donepezil; Donepezil hci (drug); Donepezil hydrochloride; Donepezil sandoz; Other: [11c]donepezil pet; Pridia (donepezil hydrochloride) 5mg; Prior donepezil 5mg; | 2件: D00670 D00670
D07869 D07869 💬 |
1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
005 9件: 5 , 6 , 13, 46, 78, 124, 127, 156, 206 💬 |
6 | Droxidopa | Droxidopa 2件: Droxidopa; Droxidopa 100 mg [northera]; | 1件: D01277 D01277 💬 |
9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
005 3件: 5 , 6 , 17 💬 |
7 | Emeramide | Emeramide 1件: Emeramide; | - |
- |
- |
005 2件: 5 , 17 💬 |
8 | Flortaucipir | Flortaucipir 2件: Flortaucipir; Flortaucipir f18; | 1件: D11210 D11210 💬 |
- |
- |
005 3件: 5 , 7 , 127 💬 |
9 | Fludeoxyglucose (18F) | - | - |
- |
- |
005 13件: 5 , 6 , 7 , 13, 34, 41, 46, 53, 84, 85, 96, 127, 300 💬 |
10 | Flutemetamol | Diagnostic test: flutemetamol f18 injection 4件: Diagnostic test: flutemetamol f18 injection; Flutemetamol; Flutemetamol f18; Vizamyl (flutemetamol(f-18)); | - |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
11 | Flutemetamol (18F) | - | 1件: D10231 D10231 💬 |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
12 | Gold | Gold 7件: Gold; Gold nanocrystals; Mtx goldshield tablets; Other: comparator: cpet cycle ergometer (gold standard); Procedure: quantiferon-tb gold assay; Procedure: repair of cdh w/sis gold; Sodium aurothiomalate (intramuscular gold); | - |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
13 | Gosuranemab | - | 1件: D11293 D11293 💬 |
1件: MAPT 💬 |
Alzheimer disease 4件: Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases |
005 1件: 5 💬 |
14 | Hydrogen | 3- (9,10- didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate 8件: 3- (9,10- didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate; Hydrocortisone hydrogen succinate; Hydrogen; Hydrogen peroxide; Lisuride hydrogenmaleate; Methylprednisolon-21-hydrogensuccinat, natriumsalz; Other: hydrogen peroxide; Tch346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt); | - |
- |
- |
005 7件: 5 , 6 , 13, 17, 83, 97, 226 💬 |
15 | Ioflupane I-123 | - | 1件: D10014 D10014 💬 |
- |
- |
002 4件: 2 , 5 , 6 , 17 💬 |
16 | Isoxaflutole | - | - |
- |
- |
005 9件: 5 , 6 , 13, 46, 81, 113, 122, 149, 299 💬 |
17 | Leucine | Administration of stable isotope-labelled leucine- 8件: Administration of stable isotope-labelled leucine-; Diagnostic test: serum leucine-rich alpha-2 glycoprotein (lrg) levels; Essential amino acid intake + leucine vs total aa supplement; L-leucine; Leucine; N acetyl l leucine; N-acetyl-l-leucine; Other: 13c6 leucine; | 1件: D00030 D00030 💬 |
- |
- |
005 10件: 5 , 6 , 7 , 19, 96, 97, 127, 283, 284, 299 💬 |
18 | Levocarnitine | Levocarnitine 4件: Levocarnitine; Levocarnitine propyl hydrochloride; Valproate, levocarnitine; Valproic acid and levocarnitine; | 3件: D02030 D02030
D02176 D02176
D04713 D04713 💬 |
- |
- |
003 10件: 3 , 5 , 13, 53, 58, 96, 97, 265, 298, 316 💬 |
19 | Lipoic acid | Alpha lipoic acid 9件: Alpha lipoic acid; Alpha-lipoic acid; Alpha-lipoic acid and l-acetyl carnitine; Lipoic acid; Lipoic acid (la) with fish oil and la without fish oil; Lipoic acid and omega-3 fatty acids; Lipoic acid group; Oral lipoic acid (la); R lipoic acid; | 2件: D00048 D00048
D00086 D00086 💬 |
- |
- |
002 5件: 2 , 5 , 13, 14, 20 💬 |
20 | Lithium citrate | Lithium citrate 1件: Lithium citrate; | 1件: D04749 D04749 💬 |
- |
- |
002 5件: 2 , 5 , 6 , 7 , 8 💬 |
21 | Masitinib | Masitinib 12件: Masitinib; Masitinib (3.0); Masitinib (4.5); Masitinib (6.0); Masitinib (ab1010); Masitinib 100 mg tablets; Masitinib 100mg; Masitinib 200 mg tablets; Masitinib 200mg; Masitinib 3 mg; Masitinib 6.0 mg; Masitinib mesylate; | 1件: D10229 D10229 💬 |
1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 6件: 2 , 5 , 6 , 13, 46, 96 💬 |
22 | Nicotinamide | Eh301 (nicotinamide riboside/pterostilbene) 3件: Eh301 (nicotinamide riboside/pterostilbene); Nicotinamide; Nicotinamide riboside; | 1件: D00036 D00036 💬 |
- |
- |
002 9件: 2 , 5 , 6 , 13, 18, 49, 67, 162, 191 💬 |
23 | Nitrogen | Device: perform three multiple breath nitrogen washout tests (n2-mbw-test) 3件: Device: perform three multiple breath nitrogen washout tests (n2-mbw-test); Nitrogen; Procedure: functional hepatic nitrogen clearance; | 1件: D00083 D00083 💬 |
- |
- |
005 6件: 5 , 6 , 17, 171, 211, 299 💬 |
24 | Raclopride | 11c-raclopride 2件: 11c-raclopride; Raclopride; | - |
- |
- |
005 4件: 5 , 6 , 7 , 17 💬 |
25 | Rasagiline | 1.0 mg rasagiline mesylate 16件: 1.0 mg rasagiline mesylate; Group r rasagiline; Group r+ad rasagiline + antidepressant; P2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),; P2b001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),; Rasagiline; Rasagiline 1 mg capsule; Rasagiline 1mg tablet; Rasagiline 2 mg tablet; Rasagiline mesilate; Rasagiline mesylate; Rasagiline mesylate 1.0 mg; Rasagiline mesylate plus mirapex; Rasagiline mesylate with levodopa; Rasagiline mesylate with requip; Rasagiline tablets; | 3件: D02562 D02562
D08469 D08469
D10829 D10829 💬 |
1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 6件: 2 , 5 , 6 , 13, 17, 66 💬 |
26 | Riluzole | Plasma from healthy young people treatment + riluzole 8件: Plasma from healthy young people treatment + riluzole; Riluzole; Riluzole (100 mg); Riluzole 50 mg; Riluzole 50 mg (part b); Riluzole oral soluble film; Riluzole oral soluble film (rosf) 50 mg; Riluzole pmcs; | 1件: D00775 D00775 💬 |
14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 8件: 2 , 3 , 5 , 8 , 13, 17, 18, 206 💬 |
27 | Rivastigmine | Exelon patch (rivastigmine transdermal system) 9件: Exelon patch (rivastigmine transdermal system); Rivastigmine; Rivastigmine capsule; Rivastigmine cf; Rivastigmine luye transdermal patch- 9.5mg/24h; Rivastigmine patch 9.5 cm2; Rivastigmine transdermal patch; Rivastigmine transdermal system; Rivastigmine transdermal system 13.3 mg/24 h; | 2件: D02558 D02558
D03822 D03822 💬 |
1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
005 3件: 5 , 6 , 13 💬 |
28 | Salsalate | Salsalate 1件: Salsalate; | 1件: D00428 D00428 💬 |
2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
005 1件: 5 💬 |
29 | Suvorexant | Suvorexant 1件: Suvorexant; | 1件: D10082 D10082 💬 |
2件: HCRTR1, HCRTR2 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
005 3件: 5 , 6 , 13 💬 |
30 | Tideglusib | Tideglusib 1件: Tideglusib; | - |
- |
- |
005 2件: 5 , 113 💬 |
31 | Tolfenamic acid | Tolfenamic acid 1件: Tolfenamic acid; | 1件: D01183 D01183 💬 |
2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
005 1件: 5 💬 |
32 | Trihexyphenidyl | Other: controls primary cervical dystonia (trihexyphenidyl) 3件: Other: controls primary cervical dystonia (trihexyphenidyl); Primary cervical dystonia (trihexyphenidyl); Trihexyphenidyl; | 2件: D00787 D00787
D08638 D08638 💬 |
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
005 2件: 5 , 6 💬 |
33 | Ubidecarenone | - | 1件: D01065 D01065 💬 |
- |
- |
002 13件: 2 , 5 , 6 , 8 , 10, 18, 46, 57, 86, 113, 193, 214, 215 💬 |
34 | Valproic acid | Valproic acid 3件: Valproic acid; Valproic acid (vpa); Valproic acid and levocarnitine; | 1件: D00399 D00399 💬 |
7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
002 16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬 |
35 | Water | 15 o water 31件: 15 o water; 15-o labeled water; 5% glucose water solution; Behavioral: diet and water adjustment; Behavioral: water tracking; Cholecalciferol concentrate (water-dispersible form); Device: manual toothbrush and water flosser (philips sonicare airfloss); Device: sonic toothbrush (philips sonicare) and water flosser (philips sonicare airfloss); Dextrose, 5% in water; High water intake; Lactose in water; Other: ad libitum water intake; Other: dead sea solar and water treatment; Other: dextrose water 5%; Other: exercise followed cold water immersion; Other: harkány medicinal water; Other: high water intake; Other: potable water; Other: water; Other: water prescription; Pl 12185/0002 & pl 12185/0005(water for injection); Procedure: water exercises; Pseudoephedrine + 480 ml water; Pseudoephedrine + 50 ml water; Sterile water; Sterile water for injection; Sterilised water for injections; Water; Water for injection; Water for injections; Water for injections, ep; | 1件: D00001 D00001 💬 |
- |
- |
002 22件: 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
36 | Zolpidem | Zolpidem 4件: Zolpidem; Zolpidem first dose; Zolpidem second dose; Zolpidem tartrate; | 2件: D00706 D00706
D08690 D08690 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
005 3件: 5 , 6 , 46 💬 |